The safety record
Non-thermal, non-invasive, no systemic exposure. There is no biological mechanism for tissue injury, and no adverse events have been reported across the clinical record.
TL;DR
No serious adverse events attributable to tPEMF have been documented across millions of treatments and the full published clinical record. The device is non-thermal (no heat), non-ionizing (no DNA damage), and non-invasive — the physics leave no pathway for tissue injury. There are clear contraindications (implanted leads, pregnancy) that must be observed, but within those boundaries the safety profile is exceptional.
tPEMF operates at roughly 4 microtesla — about 1,000 times less than the magnetic field you are exposed to holding a mobile phone to your head. The carrier frequency is 27.12 MHz, non-ionizing (far below the ionizing threshold of ~3 petahertz). The energy is non-thermal: the field intensity is calibrated to engage cellular signaling without raising tissue temperature. There is no current entering the body, no electrode contact, and no chemical exposure. The biological target — the calmodulin-NO cascade — is a normal physiologic process. The device amplifies it; it does not introduce anything foreign.
Do not use if you have any implanted electronic device with leads — pacemakers, ICDs, cochlear implants, bone-growth stimulators — even if turned off. The electromagnetic field can interact with implanted lead hardware. As additional precautions: not recommended during pregnancy, and not for use directly over open growth plates in skeletally immature patients. These contraindications are real and must be observed. Within them, the device has an exceptional safety record.
Opioids — the default alternative for post-surgical pain — carry well-documented risks: nausea, vomiting, sedation, respiratory depression, ileus, and dependence. NSAIDs carry GI and cardiovascular risks. Cortisone injections carry structural risks with repeated use. tPEMF does none of these things. In the risk-benefit calculus that drives every clinical decision, a device with zero reported adverse events and the safety profile described above competes very favorably against the standard pharmacologic alternatives.
The absence of adverse events across millions of treatments is not a lucky streak — it is the predictable consequence of the physics. Non-thermal: at 4 microtesla, tissue temperature cannot rise measurably. Non-ionizing: photon energy at 27.12 MHz is approximately 10 billion times below the threshold for ionization — no mechanism exists for DNA damage. No current: transcutaneous electrical stimulation carries burn, cardiac-conduction, and comfort risks; none of these apply to a field-based device with no electrode contact. There is no biological mechanism by which this device could cause tissue injury within its operating parameters.
A device with no reported adverse events across millions of treatments, clear physics-based reasons why injury cannot occur, and well-defined contraindications is an unusually clean addition to a clinical protocol. The prescribing clinician's safety analysis reduces to two questions: does the patient have an implanted lead-containing device, and is the patient pregnant? If no to both, the safety profile is exceptional. The absence of drug-drug interactions, systemic exposure, or organ-function monitoring requirements makes integration into complex post-surgical or wound-care protocols straightforward.
Sources & references
Related